Genmab A/S
Genmab A/S（GMAB）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
gmab · 股价预测 · 17 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 17 位华尔街分析师
Buy
17 位分析师
共识
评级分布
12 个月目标价
High
$41.50
Consensus
$38.30
+52.3% upside
Low
$32.00
Median: $40 · Last Close: $25.15
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$38.30
52.3% upside
High Target
$41.5
65.0%
Low Target
$32
27.2%
Current Price
$25.15
as of today
Based on analyst price targets, the GMAB stock price prediction for the next 12 months ranges from $32 to $41.5. The consensus GMAB price forecast of $38.30 implies 52.3% upside from the current price of $25.15.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $24.14 | ↓ 4.00% |
1-day model range: $24.04–$24.25. Peak: $24.25 (-4.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $24 | -5.9% |
| 2028 | $23 | -9.6% |
| 2029 | $22 | -11.8% |
| 2030 | $22 | -13.3% |
| 2031 | — | -14.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GMAB · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-23 | Guggenheim | Maintains | Buy→Buy |
| 2026-02-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-07 | Truist Securities | Maintains | Buy→Buy |
| 2025-10-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-24 | Guggenheim | Upgrade ↑ | Neutral→Buy |
Wall Street analysts have recently issued updated ratings on Genmab A/S (GMAB) stock. Of the recent 131 rating actions, 8 were upgrades and 7 were downgrades. 17 analysts currently cover GMAB.
分析师推荐趋势
GMAB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4.3B
↓ 29.0% YoY
Revenue Next Year
$5.1B
↑ 17.1% YoY
EPS This Year
$1.15
EPS Next Year
$1.67
↑ 45.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast GMAB EPS of $1.15 for the current fiscal year, based on estimates from 9 analysts. The GMAB revenue forecast is $4.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GMAB 股价预测由两类独立数据源支撑：来自 17 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GMAB 的共识目标价为 $38.30（+52.3% 上行空间），分析师共识为 Buy。
GMAB 的短期预测（明日）为 $24.14（-4.00%）。 GMAB 对 2027 年的股价预测均值为 $24。 GMAB 对 2030 年的预测区间为 $21–$23。
Genmab A/S 在 NASDAQ 上市，代码 GMAB。GMAB 在 2027 年的整体展望偏积极，在覆盖分析师中约 71% 对应 Buy 共识。
常见问题
GMAB 预测 · 8 个问题根据 17 位华尔街分析师，GMAB 的 12 个月平均目标价为 $38.30，最高 $41.50、最低 $32.00。若有图表，中位目标价可在上方查看。相对当前价 $25.15，隐含约 +52.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.